Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics episode artwork

EPISODE · Sep 8, 2025 · 32 MIN

Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics

from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Saurabh Johri, Chief Business Officer at Catena Biosciences, a pioneering company revolutionizing protein conjugation technologies for next-generation therapeutics. Saurabh shares insights on Catena’s platform, its potential to reshape therapeutic development, and the company’s vision for advancing precision medicine through novel protein engineering approaches.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on June 6, 2025.

Episode metadata supplied by the publisher feed · Published Sep 8, 2025

Embed this episode

NOW PLAYING

Saurabh Johri | Chief Business Officer, Catena Biosciences – Revolutionizing Protein Conjugation for Next-Generation Therapeutics

0:00 32:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Executive Insights for Life Sciences Innovators?

This episode is 32 minutes long.

When was this Executive Insights for Life Sciences Innovators episode published?

This episode was published on September 8, 2025.

Can I download this Executive Insights for Life Sciences Innovators episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!